Next Quarterly Earnings
Thursday, October 29, 2026
Expected
Nuvalent
Nuvalent develops novel medicines for the treatment of cancer, particularly solid tumors. This US-based company focuses on the discovery and development of therapies targeting specific genetic mutations to improve patients' lives.
Frequently asked questions
When did Nuvalent last report quarterly earnings?
Nuvalent last reported quarterly earnings on 5/7/2026 (Q1 2026). Earnings per share (EPS) came in at -1.39 USD.
How often has Nuvalent beaten expectations?
Nuvalent has beaten analyst EPS estimates in 0 of its last 4 evaluated quarters (beat rate: 0%).
How do I add the Nuvalent earnings dates to my calendar?
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
All Dates
Earnings statistics
Estimates vs. results
0/4
Quarters above estimates
0%
Beat rate
-2.8%
Avg. EPS surprise
Basis: 4 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.
Company Information
Name
Nuvalent
Country
🇺🇸
More Financial Information